Childhood absence epilepsy: Poor attention is more than seizures

Neurology

Volumn 81, Issue 18, 2013, Pages

  Thio, Liu Lin ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ETHOSUXIMIDE; LAMOTRIGINE; VALPROIC ACID;

ARTICLE; ATTENTION DEFICIT DISORDER; BRAIN FUNCTION; CHILDHOOD ABSENCE EPILEPSY; COGNITIVE DEFECT; HUMAN; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; TREATMENT DURATION; ABSENCE; COGNITION DISORDERS; COMPLICATION; FEMALE; MALE; UNITED STATES;

COGNITION DISORDERS; EPILEPSY, ABSENCE; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; UNITED STATES;

EID: 84888261015     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000436060.67147.25     Document Type: Article

References (3)

1. Masur D, Shinnar S, Cnaan A, et al. Pretreatment cognitive deficits and medication impact on attention in childhood absence epilepsy. Neurology 2013;81:1572-1580.
2. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362:790-799.
3. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy: initial monotherapy outcomes at 12 months. Epilepsia 2013;54:141-155.